Accueil › Leucémie aiguë myéloïde › District de Columbia › Washington
Essais cliniques pour Leucémie aiguë myéloïde à Washington, DC
24 études pour Leucémie aiguë myéloïde recherchent des participants dans et autour de Washington (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Recrutement en coursPhase 2
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Recrutement en coursPhase 1
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Recrutement en coursPhase 3
- Center for Cancer and Blood Disorders, Bethesda · à 7 mi
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Recrutement en coursPhase 2
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Recrutement en coursPhase 3
- MedStar Georgetown University Hospital, Washington D.C.
- Children's National Medical Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
Longitudinal Studies of Patient With FPDMM
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Recrutement en coursPhase 1/2Volontaires sains bienvenus
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Recrutement en coursÉtude observationnelle
- The Center for Cancer and Blood Disorders, Bethesda · à 7 mi
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Recrutement en coursPhase 1/2
- Children's National Medical Center, Washington D.C.
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Recrutement en coursPhase 3
- Children's National - Main Hospital, Washington D.C.
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
Recrutement en coursPhase 1
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
Recrutement en coursPhase 1
- Childrens National Medical Center, Washington D.C.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recrutement en coursÉtude observationnelle
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · à 7 mi
- Nih/Nhlbi, Bethesda · à 7 mi
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Recrutement en coursPhase 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · à 7 mi
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Cancer Support Community Research & Training Institute, Washington D.C.
Massage Impact on Sleep in Pediatric Oncology
Recrutement en cours
- Children's National Hospital, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Recrutement en coursPhase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Phase IB/II of CPX-351 for Relapse Prevention in AML
Recrutement en coursPhase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Essais pour Leucémie aiguë myéloïde dans d'autres villes
- Houston, TX85 études
- New York City, NY51 études
- Boston, MA44 études
- Seattle, WA41 études
- Baldwin Park, CA40 études
- Columbus, OH35 études
- Philadelphia, PA34 études
- Durham, NC33 études
- Atlanta, GA31 études
- Tampa, FL29 études
- Chicago, IL26 études
- Portland, OR25 études
Autres études à Washington
- Cancer (tous types)58 études
- Cancer du poumon non à petites cellules55 études
- Cancer du sein46 études
- Cancer métastatique43 études
- Cancer du poumon41 études
- Cancer de la prostate38 études
- Obésité33 études
- Cancer colorectal29 études
- Maladie cardiovasculaire28 études
- Cancer de la vessie26 études
- Cancer de l'ovaire23 études
- Lymphome23 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.